Multiple Myeloma Includes Phenotypically Defined Subsets of Clonotypic CD20+ B Cells that Persist During Treatment with Rituximab

Potential progenitor B cell compartments in multiple myeloma (MM) are clinically important. MM B cells and some circulating MM plasma cells express CD20, predicting their clearance by treatment with anti-CD20. Here we describe two types of clonotypic CD20+ B cell in peripheral blood of myeloma patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilarski, Linda M., Baigorri, Eva, Mant, Michael J., Pilarski, Patrick M., Adamson, Penelope, Zola, Heddy, Belch, Andrew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161648/
https://www.ncbi.nlm.nih.gov/pubmed/21892289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161648/
https://www.ncbi.nlm.nih.gov/pubmed/21892289

Ejemplares similares